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Purpose: The telomere binding proteins play an important role in telomere function, which contribute greatly to
the radio resistant in human cancers. This research is designed to investigate the relationship among the telomere
length, telomerase activity and changes of telomere binding protein PTOP and TRF1 in radio resistant breast cancer
cell lines.
Methods: Irradiate MDA-MB-435 s breast cancer cell with total dose of 60 Gy delivered in 2 Gy/fraction and 6 Gy/fraction
respectively, then measuring their telomere length by Southern blot analysis,telomerase activity by Telomerase PCR Elisa
and detecting the expression of PTOP and TRF1 in both gene and protein levels. To further investigate the function of
PTOP, using lentivirus technic to silence the PTOP gene and the detected the new silenced cells by southern blot and
telomerase activity.
Results: 2 radio resistant breast cancer cell lines were successfully established. The MDA-MB-435 s R60/6 was (approximate
8.1-8.6 kbp) about 2–2.4 folds to the patent cell (3.6-4.2 kbp), the MDA-MB-435 s R60/2 cell (approximate 5.3-6.3 kbp) was
about 1.3-1.75 fold to the parent cell line. The telomerase activity was more enhanced in radio resistant cell lines than the
parent cell. The expression of PTOP and TRF1 were significant increased in radio resistant cell lines than the patent cell
in both gene and protein level. Otherwise, after using lentivirus technic to silence the PTOP gene, we found the radio
resistant cell lines were significant decrease their radio resistances and telomerase activities.
Conclusion: The telomere binding protein PTOP and TRF1 were increased expressed in radio resistant breast cancer cell,
PTOP was observed instinct positive correlated with telomere lengthen and telomerase activity enhancement.
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Telomere, caps the end of the mammalian chromo-
somes, is composed of repeated “5′-TTAGGG-3’” DNA
sequences and telomere binding proteins, serves in the
protecting of the degradation of chromosome and intra-
cellular signaling for regulating cell proliferation [1-3].
The telomere binding proteins, also called shelterin
complex, contains PTOP, TRF1, TRF2, TIN1, TIN2 and
POT1, are essentials for telomere function. Some re-
search claim that the PTOP and TRF1 play an important
role in interaction with other proteins and the length
regulation also has some relations to the telomerase activ-
ity [4,5]. Our previous research demonstrated there were
some relationships with telomere length and cellular radio* Correspondence: yfzhouwhu@163.com
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stated.resistance [6]. Furthermore an increase expression of
PTOP was observed in a radio resistant human larynx
squamous carcinoma [7]. However, this point has not
been confirmed in the breast cancer cell lines. This study
is designed to investigate the relationships among the telo-
mere length, telomerase activity and the expression of
some telomeric proteins in breast radio resistance cells.Results
Establish radio resistant breast cancer cell mode
Using X-ray to irradiate the MDA-MB-435 s cell to 60 Gy
total dose by 2 Gy/fraction and 6 Gy/fraction respectively.
MDA-MB-435 s R60/2 and MDA-MB-435 s R60/6 cells
were passaged until the 8th generation. The 1st, 5th and
8th cells were collected for the clonogenic assay. The cell
survival curves of Figure 1A and B demonstrated the
radiobiological parameters of each groups. The survivalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Clonogenic assay. A and B described the cell survival condition after irradiation. X-ray irradiation was performed as planed in 6 Gy/fraction
and 2 Gy/fraction with total dose 60 Gy. An appropriate number of cells in different generations were seed in 6-well plates. Each group was irradiated
at the dose of 0 Gy, 1 Gy, 2 Gy, 4 Gy, 6 Gy, 8 Gy, 10 Gy, respectively. After incubation for 14 days, the colonies were fixed and stained by crystal violet.
The colonies > 50 cells were scored as viable colonies. The data was analyzed by single-hit multi-target model and survival curve of each group was
described by Graphpad prism 5.0 software.
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MDA-MB-435 s R60/2 were much higher at each point
than the MDA-MB-435 s cell. And Figure 2A and B de-
scribed the changes of SF2 in different generation of irra-
diated cells. Each generation of irradiated cells were
higher than the parent cell and stay relatively stable. The
radiobiological parameters calculated in Table 1 showed
that, D0, Dq and SF2 values in MDA-MB-435 s, MDA-
MB-435 s R60/6 and MDA-MB-435 s R60/2 on average.
The Irradiated groups were significant higher than the
parent cell line (p < 0.05). The MDA-MB-435 s R60/6 cell
and MDA-MB-435 s R60/2 cell were observed as stable
and radio resistant cell lines.
The changes of telomere ponding proteins (PTOP and TRF1)
With an irradiation of 60 Gy, we detected there were some
changes in telomere ponding proteins, such as PTOP and
TRF1 (Figures 3 and 4). Western blot and qRT-PCR were
used to evaluated the changes of PTOP and TRF1 in bothprotein and mRNA level. Compared with the MDA-MB-
435 s group, the expression of irradiated groups were in-
creased in both protein and mRNA level. The results sug-
gested highly expressed PTOP and TRF1 had some
relationship with radio resistance.
The telomere length exam
To further investigate the relationship between telomere
length and telomere ponding protein, Southern blot
analysis was performed. In Figure 5, the results showed
the MDA-MB-435 s R60/6 and MDA-MB-435 s R60/2
cell lines were significant longer than the parent cell.
We calculated the average telomere length of irradiated
groups, the mean TRF (terminal restriction fragment)
of MDA-MB-435 s R 60/6 cell line (approximate 7.2-
8.6 kbp) was about 2–2.4fold to the MDA-MB-435 s cell
(Approximate 3.6-4.2 kbp), the MDA-MB-435 s R 60/2
cell line (approximate 5.3-6.3 kbp) was about 1.3-1.75
fold to the parent cell line. These results suggested the
Figure 2 SF2 in different generation. A and B demonstrated the changes among non-irradiated group and irradiated groups. All the irradiated
groups in 2A and 2B were increased greatly than the non-irradiated cell (MDA-MB-435 s). Although a slight decrease were observed along the
generation, all the values of SF2 were significant higher than the MDA-MB-435 s cell. The SF2 of parent cell were 0.3655 ± 0.0334, the 1st, 5thand
8th generation of 60/6 cell lines were 0.5224 ± 0.0534, 0.5628 ± 0.0611, 0.5387 ± 0.0225, respectively. The 1st, 5th and 8th generation of 60/2 were
0.5224 ± 0.0534, 0.5627 ± 0.0611, 0.4687 ± 0.0225, respectively. Compare with the parent cell line, the 60/6 and 60/2 cell lines all increased their
radio resistivity and stay persistent, p < 0.05.
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telomere length than the normal expressed one.
The results of telomerase activity in different groups
To investigate whether the elongated telomeres had in-
creased telomerase activity, the cells of 3 groups were de-
tected by telomerase activity assay. Compare with the
MDA-MB-435 s cell line, the MDA-MB-435 s R60/6 and
MDA-MB-435 s R60/2 cell lines were increased in tel-
omerase activity in Figure 6. *p < 0.05, was considered sig-
nificant. The highly expressed PTOP and TRF1 groups
were observed having increased telomerase activity.
Verify the effect of PTOP knocking down cell lines
Whether PTOP regulate the radio resistance of the
breast cancer cell, we knocked downed the PTOP gene
by lentivirus technic. To verify the effect of knocking
down, western blot and qPT-PCR were performed in
MDA-MB-435 s, MDA-MB-435 s 60/6 LV-PTOP-RNAi
(60/6 PTOP RNAi for short) and MDA-MB-435 s R60/2
LV-PTOP-RNAi (60/2 PTOP RNAi for short) cell lines.
In Figures 7 and 8, compare with the MDA-MB-435 s
cell, the expression of 60/2 PTOP RNAi and 60/6 PTOP
RNAi cells were significant decreased. These resultsTable 1 Radiobiological parameters in different groups
Groupings D0 Dq SF2
MDA-MB-435 s 1.372 ± 0.012 0.413 ± 0.033 0.365 ± 0.008
MDA-MB-435 s R60/2 3.782 ± 0.041* 0.667 ± 0.015* 0.646 ± 0.024*
MDA-MB-435 s R60/6 2.563 ± 0.028* 0.593 ± 0.189* 0.534 ± 0.006*
Data were fit into the single-hit multi-target model, and survival curves of both
groups were drawn by Graphpad Prism, the SF2, D0, Dq values were calculated
(pD0, Dq, SF2 < 0.05). Data were expressed as the mean ± SD. * p <0.05 were
considered significant. D0: mean lethal dose, Dq: quasi-threshold dose, SF:
surviving fraction.suggested the new PTOP silenced cell lines were well
conducted for further experiments.
Changes of radio resistance by knocking down PTOP
Whether PTOP was the key factor to the radio resistance,
the clonogenic assay would clearly tell us on basis of such
well-established PTOP silence cell lines. The MDA-MB-
435 s, 60/2 PTOP RNAi and 60/6 PTOP RNAi cells were
collected and seed in 6-well plates. Followed the same
procedures as above, the results suggested 2 PTOP si-
lenced cell lines both decrease their radio resistance
but still radio sensitive than the MDA-MB-435 s cell in
Figure 9. These results revealed that the existing of PTOP
would changes the radio resistance of breast cancer cell.
Changes of telomere activity of PTOP Knocking down
cell lines
After we performed the telomerase activity assay, we
found the PTOP also played an important role in telomer-
ase activity. In Figure 10, the bar graph showed compare
with the MDA-MB-435 s cell, the PTOP silenced groups
were slight increase their telomerase activity, but had no
significant differences. Which meant, lacking of PTOP
would decrease the telomerase activity.
Discussion
In the guidelines of the breast cancer, radiotherapy takes
a great part in the treatment strategy and influence the
prognosis of the patients. How to enlarge the effect of
the radiotherapy or avoid the radio resistance? These
questions lead us to do this research.
In our study, the telomere binding protein PTOP and
TRF1, as the important mediators of telomere maintenance,
were significant highly expressed in breast radio resistant
Figure 3 Changes of PTOP and TRF1 proteins in different groups. (A and B) Western blot showed the protein of PTOP and TRF1 in
irradiated groups were significant over expressed than the non-irradiated group (MDA-MB-435 s). (3C and 3D) The bar chart demonstrated the
semiquantitative analysis of PTOP and TRF1 expression. Data represented means ± SD,*p < 0.05 was considered significant.
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the 2 breast radio resistant cell lines, the MDA-MB-
435 s R60/6 showed longer telomere length and higher
telomerase activity.
These 2 radio resistant cell lines were established by
the same parent cell and share the similar tumor charac-
teristic. Their resistances were measured by cell sur-
vival curve. Although they maintained resistance, a
slight decrease of radio resistance still can be observedFigure 4 Changes of PTOP and TRF1 mRNA in different groups. qTR-P
non-irradiated and irradiated groups. The results (4A and 4B) showed th
Bar graph showed the mean ± SD value of relative mRNA expression, *pin the 5th and 8th generation. Some research explains,
because of the absence of the selecting radiation pres-
sure, the radio resistant modes will lose their ability
gradually. It is postulated that the radiation pressure has
the favored the emergence of radio resistant cell lines
during fractionated irradiation [8]. Li [9] et al. irradiate
human breast cancer cell MCF-7 in total 40 Gy deliv-
ered in 2 Gy per fraction, lost the radio resistance after
12 generations.CR was used to evaluated PTOP and TRF1 mRNA expression in
e relative levels of PTOP and TRF1 mRNA compare with GAPDH.
< 0.05 was considered significant.
Figure 5 Southern blot analysis. Telomere length was detected
by Southern blot analysis. The results were analyzed by image
system software (Bio-Rad).
Figure 6 Telomerase activity in different groups. The telomerase
activity was performed by telomerase activity assay. Compare with the
MDA-MB-435 s cell line, the MDA-MB-435 s R60/6 and MDA-MB-435 s
R60/6 cell lines had increased telomerase activity.
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were positive correlated. At meanwhile, among these 3
cell lines, we found that the telomerase activity was posi-
tive correlated with telomere length. Wesbuer [10] et al.
investigate the human neuroblastomas, find out that in-
crease the telomere length would lead to the decreasing
of radio sensitivity, and the telomerase negative cells are
significant more sensitive to irradiation. The same phe-
nomena are observed in murine lymphoma cell and hu-
man primary lung cancer [11,12]. Taken together, these
data suggest that telomere length and telomerase activity
may be used as a potential diagnostic marker for detect-
ing radio resistance.
TRF1, is engaged in multiple roles at telomere including
telomere protection, telomere replication, sister telomereresolution and telomere length maintenance [13]. TRF1
was expected as a negative regulator of telomere length fac-
tor, could reduce the activity of telomere at the beginning
[14]. However, in our study, not only the gene but also the
protein level, it seemed that TRF1 had a positive relation-
ship with the telomere length and telomerase activity. Inter-
estingly,the similar phenomena are observed in acute
leukemia cell and pancreatic cancer cells [15,16]. Some re-
search explains because the expression of TRF1 may be re-
lated to hTERT (human telomerase reverse transcriptase)
expression. Furthermore, the c-MYC gene plays an import-
ant role in the promoter region of hTERT, which is widely
over expressed in breast cancer. hTERT is up-regulated by
c-MYC independently from cell proliferation and negative
influenced by TRF1 [17,18]. Therefore, the relationship be-
tween TRF1 and telomerase activity might due to other fac-
tors, such as hTERT, c-MYC and so on.
PTOP, known as TPP1, is considered directly interact
with the telomerase for recruitment to telomere [19], helps
in stabilizing the TRF1-TIN1-TRF2 interaction. From the
results of our study, we observed that in the radio resistant
cell lines, the PTOP was highly expressed. Meanwhile,
when we knock downed the PTOP gene of the radio resist-
ant cell lines, a dramatically decrease of radio resistance
was appeared and a slight decrease of telomere activities
were also observed. Some other research also pointed out,
knocking down the PTOP reduced the ability of en-
dogenous TRF1 associate with TRF2 [20]. Although the
mechanism of recruitment remains unclear, the results
of out study provide the evidence that PTOP had a close
relationship with intrinsic radio resistance and telomere
activity. Many other research have also demonstrated
that the PTOP helps in extending the telomere length
Figure 7 Knocking down PTOP protein in different groups.
Western blot showed the PTOP knocking down expression in different
groups. Compare with the MDA-MB-435 s cell, the expression of 60/2
PTOP RNAi and 60/6 PTOP RNAi cells were significant decreased. The
bar graph showed the semiquantitative analysis of PTOP knocking
down expression. Data represented means ± SD, *p < 0.05 was
considered significant.
Figure 8 mRNA expression of Knocking down PTOP in different
groups. The results showed the relative levels of silenced PTOP
mRNA compare with GAPDH in 3 cell groups. Bar graph showed
the mean ± SD value of relative mRNA expression, *p < 0.05 was
considered significant.
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other telomere binding proteins, and even influence the
radio sensitivity of other cancer cells. From our study, it
was clear that regulating the radio resistance was a huge
and complicate process, although PTOP played an ex-
tremely crucial role in regulation, other proteins also took
parts in the this reaction [21-25].
Conclusion
Our research provided that the hypo fraction irradiation
could establish a more radio resistant breast cancer cell,
with longer telomere and more active telomere. High levels
of PTOP and TRF1 genes were expressed in the radio re-
sistance breast cancer cells, knocking down the PTOP re-
duced the radio resistance and the telomere activity. Why
we couldn’t block completely the radio sensitivity com-
pletely by knockdown the PTOP, are there any other genes
interact with this gene. The further research will be de-
signed through this promising direction.Methods
Cell culture
MDA-MB-435 s is a mammary gland breast cancer cell,
originally described as a spindle shaped variant of the
parental MDA-MB-435 cell. The cells were maintained
in RPMI 1640 medium supplemented with 10% fetal bo-
vine serum and incubated at 37°C in 5% CO2/95% air.
The cells were sub cultured every 2 to 3 days in vented
25-cm2 cell culture flasks.
X-ray irradiation
MDA-MB-435 s radio resistant cells modes were built in
2 ways. One was MDA-MB-435 s R60/6, the other was
MDA-MB-435 s R60/2. All the cells were first grown to
approximately 90% confluence then irradiated by a Simens
Primus Accelerator at an average dose rate of 2.0 Gy/min,
60/6 were received 6 Gy/fraction; 60/2 were received
2 Gy/fraction. The total dose were 60 Gy respectively.
Clonogenic assay
The standard clonogenic assay was performed as de-
scribed [26,27]. Cells were trypsinzed at room temperature
for 30-60 sec, pipetted the clumped cells. The single cell
suspension was adjusted and seeded into typical 6 flasks.
Then, cells were left to settle over night, and exposed to
irradiation at room temperature over the dose range 0-10
Gy, followed by incubation at 37°C, 5% CO2 for 14 days.
After fixation and staining, colonies of >50 cells were
Figure 9 Changes of radio resistance by knocking down PTOP. A and B showed the different cell survival curves among the MDA-MB- 435s
cell, radio resistant cell lines and PTOP silenced cell lines. Each group was irradiated at the dose of 0 Gy, 1 Gy, 2Gy, 4 Gy, 6 Gy, 8 Gy, 10 Gy, respectively.
The same procedures were performed as above. The data was analyzed by single-hit multi-target model and survival curve of each group was de-
scribed by Graphpad prism 5.0 software.
Figure 10 Changes of telomerase activity by knocking down
PTOP. The telomerase activity was performed by telomerase activity
assay. Compare with the MDA-MB-435 s cell line, the PTOP silenced
groups had no statistical differences. *p > 0.05
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diation treated controls.
Western blot
All the proteins were isolated from cells by RIPA lysis
buffer, separated on SDS-PAGE, and transferred to
PVDF membranes. After blocked, the membranes were
incubated with first antibodies anti-PTOP and anti-
TRF1 (1:1000) at 4°C overnight, then incubated with sec-
ondary antibodies (1:1500) at 37°C for 2 h and detected
by ECL solution, then tape the membrane to inside film
cassette then exposed the membrane to film with x-ray
in the dark. Anti-PTOP antibody (ab57595) was from
abcam®, Anti-TRF1 antibody (Cat.#04-638) was from
Millipore®.
qRT-PCR
Total RNA was isolated by TRIzol reagent. The ana-
lysis was performed as described [28]. The forward and
reverse primers of each gene were as follow: GAPDH
were 5′-tggaaggactcatgacaca-3′ and 5′-ttcagctcagggat-
gacctt-3′, PTOP were 5′-atctcgAagtatgcctggccgctgtca-
gagtg-3′ and 5′-agcggccgctatcacatcggagttggctcagac- 3′,
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aagggtg-3′, respectively. All the primers were composed
by Invitrogen® company. Each cycle consisted on denatur-
ation at 94°C for 30s, annealing at 58°C for 30s, extension
at 72°C for 30s. All the samples were tested by at least 3
times. All the experiments were carried out on Mx3000P
(stratagene) and the results was analyzed using the MXP
3000 analysis program.
Southern blot analysis
Mean telomere length was measured by TRF analysis using
the Telo TAGGG Telomere Length Assay Kit(Roche). Each
sample was digested with 4 μg DNA by mixture of Hinf
I and Rsa I enzymes for at least 2 hours. Then the DNA
fragments were electrophoresed by agarose gel and
transferred on a nylon membrane by southern blotting.
The Blotted DNA fragments were hybridized to a DIG-
labeled probe. The mean terminal restriction fragments
length was repeats 4 times and valued by image system
software (Bio-Rad).
Telomerase activity assay
The PCR-based telomerase assay was performed as de-
scribed [29]. In brief, 4 × 105cells were harvested and
followed the protocol of Telo TAGGG Telomerase PCR
ELISA (Roche).
Lentivirus and transfection
The knockdown products of LV-PTOP-RNAi was com-
posed by Genechem® company. The target PTOP se-
quence was 5′- GTGGTACCAGCATCAGCCT-3′, the
NC sequence was 5′- TTCTCCGAACGTGTCACG T-
3′, respectively. Both MDA-MB 435 s R60/2 and 60/6
cells were seeded in 6-well culture plates at the density
of 1 × 105cells/well 24 hours before transfection. In the
procedure of transfection, the culture medium was re-
placed by 2 ml serum-free, antibiotics-free DMEM, the
virus solution and polybrene mixture. The cells were in-
cubated for 8-10 h at 37°C in 5% CO2/95% air. Then the
medium was completely replaced and continued to incu-
bate for at least 72 h. Then the cells were collected and
determinate the expression level of PTOP mRNA by
qRT-PCR , the level of PTOP protein by Western Blot.
Statistical analysis
All the data were obtained from triplicate samples and
recorded as the mean ± standard deviation (SD). Statis-
tical analyses were performed by χ2 test. Statistical ana-
lysis was used by software SPSS 10.0 and Graphpad
Prism 5.0 c. P < 0.05 was considered to be statistically
significant.
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